Hint mode is switched on Switch off
For swift navigation between sections

Exscientia
LEI 2138003W9MAQ9O9B6535

PDF download

Choose all Reset all
Download Cancel
Organization name
Exscientia Ltd
Country name
United Kingdom
Country of registration
United Kingdom
Industry
Pharmaceutical Preparation and Biotechnology
Public debt
-

Upgrade to Premium features

Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market

Get access
Welcome to Cbonds

  • Full access to the largest bond database

    Bond parameters,
    prospectuses

  • Seamless
    Data export

    Analyze the data in the most efficient way

  • Bond pricing

    Current & historical quotes from 400+ stock exchanges & OTC market

  • Smart risk assessment

    Credit ratings, financial reports

Get access

Latest data on

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Quotes

Request sent
Access denied
Send request
Quotes provided by information providers are indicative in nature

Profile

Exscientia Ltd is an artificial intelligence pharmaceutical company that strives to find and develop the best possible drug in the fastest and most effective way.

Awards

News

15/08/2024 Exscientia Business Update for Second Quarter and First Half 2024
17/05/2023 Exscientia to Report First Quarter 2023 Financial Results on May 24, 2023
23/03/2023 Exscientia Business and Financial Update for the Full Year 2022
16/03/2023 Exscientia to Report Full Year 2022 Financial Results on March 23, 2023
15/11/2022 Exscientia Business and Financial Update for the Third Quarter 2022
All organization news

Documentation

IFRS/US GAAP reports

2023
IV q eng
2022
IV q eng
2021
IV q eng
Show all Hide
Authorization required
You need to request access

Stocks

Public debt by currencies

Show more Hide

Codes

  • LEI
    2138003W9MAQ9O9B6535
  • SIC
    2836 BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
  • CIK
    0001865408
Registration is required to get access.